Constantin G. Ioannides
- Immunology top 1%
- Oncology top 2%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Genetics top 10%
- Co-authors
- J. Taylor WhartonBryan FiskTana BlevinsGeorge E. PeoplesCatherine A. O’BrianJames L. MurrayNancy E. WardRalph S. Freedman
- Topics
- Immunotherapy and Immune Responses (55 papers)Monoclonal and Polyclonal Antibodies Research (31 papers)Immune Cell Function and Interaction (25 papers)
- Journals
- Proceedings of the National Academy of SciencesThe Journal of Experimental MedicineJournal of Clinical Oncology
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Constantin G. Ioannides
76 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 96
- Immunology 2.4k
- Oncology 1.5k
- Molecular Biology 1.3k
- Radiology, Nuclear Medicine and Imaging 889
- Genetics 199
Countries citing papers authored by Constantin G. Ioannides
This map shows the geographic impact of Constantin G. Ioannides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantin G. Ioannides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantin G. Ioannides more than expected).
Fields of papers citing papers by Constantin G. Ioannides
This network shows the impact of papers produced by Constantin G. Ioannides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantin G. Ioannides. The network helps show where Constantin G. Ioannides may publish in the future.
Co-authorship network of co-authors of Constantin G. Ioannides
This figure shows the co-authorship network connecting the top 25 collaborators of Constantin G. Ioannides. A scholar is included among the top collaborators of Constantin G. Ioannides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantin G. Ioannides. Constantin G. Ioannides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Distinct patient responses to activation of T-cells by free HER-2, G89 (777-789) and protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} peptides could lead to development of personalized cancer vaccines. | 2 |
| 2 | 5 | |
| 3 | 29 | |
| 4 | 64 | |
| 5 | Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15. | 2 |
| 6 | 25 | |
| 7 | 204 | |
| 8 | Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes. | 3 |
| 9 | Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer. | 119 |
| 10 | Helper peptide G89 (HER-2:777-789) and G89-activated cells regulate the survival of effectors induced by the CTL epitope E75 (HER-2, 369-377). Correlation with the IFN-gamma: IL-10 balance. | 5 |
| 11 | 23 | |
| 12 | 3 | |
| 13 | 27 | |
| 14 | Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals. | 40 |
| 15 | 10 | |
| 16 | 9 | |
| 17 | Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients. | 44 |
| 18 | Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes. | 28 |
| 19 | 25 | |
| 20 | 29 |
About Constantin G. Ioannides
Constantin G. Ioannides is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 76 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (55 papers), Monoclonal and Polyclonal Antibodies Research (31 papers) and Immune Cell Function and Interaction (25 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (1.5k citations) and Radiology, Nuclear Medicine and Imaging (889 citations). Constantin G. Ioannides has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include J. Taylor Wharton, Bryan Fisk, Tana Blevins, George E. Peoples, Catherine A. O’Brian, James L. Murray, Nancy E. Ward, Ralph S. Freedman, Chris D. Platsoucas and Theresa L. Whiteside. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.